Johnson Investment Counsel Inc. lessened its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,317,146 shares of the company's stock after selling 22,301 shares during the period. Procter & Gamble comprises 3.3% of Johnson Investment Counsel Inc.'s investment portfolio, making the stock its 5th biggest holding. Johnson Investment Counsel Inc. owned about 0.10% of Procter & Gamble worth $369,168,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Stableford Capital II LLC boosted its holdings in Procter & Gamble by 1.1% in the first quarter. Stableford Capital II LLC now owns 5,817 shares of the company's stock valued at $993,000 after purchasing an additional 61 shares in the last quarter. Bernard Wealth Management Corp. boosted its holdings in Procter & Gamble by 20.2% in the first quarter. Bernard Wealth Management Corp. now owns 375 shares of the company's stock valued at $64,000 after purchasing an additional 63 shares in the last quarter. B & T Capital Management DBA Alpha Capital Management boosted its holdings in Procter & Gamble by 2.3% in the first quarter. B & T Capital Management DBA Alpha Capital Management now owns 2,795 shares of the company's stock valued at $476,000 after purchasing an additional 63 shares in the last quarter. Private Management Group Inc. boosted its holdings in shares of Procter & Gamble by 4.8% in the 1st quarter. Private Management Group Inc. now owns 1,384 shares of the company's stock valued at $236,000 after buying an additional 64 shares in the last quarter. Finally, Lantz Financial LLC boosted its holdings in shares of Procter & Gamble by 1.2% in the 2nd quarter. Lantz Financial LLC now owns 5,237 shares of the company's stock valued at $834,000 after buying an additional 64 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Down 0.6%
Procter & Gamble stock opened at $149.69 on Friday. Procter & Gamble Company has a twelve month low of $149.45 and a twelve month high of $180.43. The stock has a 50 day moving average of $155.24 and a two-hundred day moving average of $159.48. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same period last year, the company earned $1.40 earnings per share. The company's revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Analyst Ratings Changes
PG has been the subject of several research analyst reports. Bank of America lowered their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a report on Wednesday. UBS Group decreased their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday. BNP Paribas Exane decreased their target price on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research report on Tuesday, September 23rd. JPMorgan Chase & Co. decreased their target price on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research report on Friday. Finally, Evercore ISI reissued an "in-line" rating and issued a $170.00 price objective (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $172.21.
Read Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling
In other news, COO Shailesh Jejurikar sold 3,986 shares of the firm's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the sale, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jennifer L. Davis sold 3,227 shares of the firm's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
